Leading Study on Malaria Drug for Coronavirus Retracted: ‘Based on This Development, We Can No Longer Vouch for the Veracity of the Primary Data Source’

Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information that’s been widely questioned by other scientists.

Thursday’s retraction in the journal Lancet involved a May 22 report on hydroxychloroquine and chloroquine, drugs long used for preventing or treating malaria but whose safety and effectiveness for COVID-19 are unknown.

Read More

Commentary: The Food Nannies Are Coming to Protect You From Burgers and Soda

by Bill Wirtz   The Lancet Recommendation In a report published in The Lancet at the end of January, lead author Boyd Swinburn makes the case for greater government intervention in order to reduce the public health effects of malnutrition. The 56-page report is a long list of known policy…

Read More